Pfizer
Jeffrey Kindler rewarded by Pfizer for his influence with governments
Submitted by KEI Staff on 9. March 2010 - 14:42On July 28, 2006, Jeffrey Kindler replaced Hank McKinnell as CEO of Pfizer. That day the Pfizer stock price closed at $26.11. With the stock trading today at a little more than $17, it would seem that shareholders have lost a significant amount of their investment. Nonetheless, Kindler is doing well.
Speech of Mike Foster, UK Minister for International Development at launch of Industry Government Forum on Access to Medicines
Submitted by thiru on 21. October 2009 - 4:32On October 12, 2009, the "Industry Government Forum on Access to Medicines" (IGFAM) was launched. The UK Minister for International Development, MP Mike Foster made a a speech to launch this initiative which is reproduced below.
Presentations were also made by Pfizer (Ponni Subbiah), GSK (Abbas Hussain), Rajiv Venkayya (Gates Foundation), Prashant Yadav (Massachusetts Institute of Technology) and Suerie Moon (Research Fellow and Doctoral Candidate, Kennedy School of Government, Harvard University).
Pfizer (PFE) Joint Ventures, Partnerships, and Alliances
Wednesday, 05 September 2007
Experimental Biology and Medicine reports that Pfizer, which has historically made very few collaborative efforts, now actively recruits partners in biotech, as well as small and midsized pharma. An unnamed source notes that, "In 2005 Pfizer entered into over 500 research collaborations, and our dynamic portfolio always holds at least 50 major collaborations." http://www.ebmonline.org/cgi/content/full/231/11/1690
Pfizer (PFE) Select Joint Vent
Pfizer shifts more money to Democrats
Submitted by James Love on 21. July 2009 - 15:00According to data from OpenSecrets.Org, from 1992 to 2006, Pfizer gave 74 percent of its campaign contributions to Republicans. Since then, particularly after Hank McKinnell left as CEO, Pfizer is giving slightly more to democrats than to republicans. In the current cycle, 54 percent of contributions go to democrats.
